Welmedis
GmbH

Welmedis GmbH’s vision is a world in which people can make well-informed decisions about their health. To achieve this, Welmedis has assembled a team of geneticists and scientists who use cutting-edge technologies to advance new scientific knowledge, develop new products, and raise standards in health, medicine, and well-being. The company’s research and development department has an established drug development pipeline that can be used for the design, synthesis, optimization, validation, and formulation of novel anti-cancer agents. Welmedis was founded in 2016 and is headquartered in Switzerland.

Welmedis GmbH
Schönenbergstrasse 12
CH-8820 Wädenswil
welmedis.com

Founder & CEO

office@welmedis.com